Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identified human breast milk compositions effectively inhibit SARS-CoV-2 and variants infection and replication
Xinyuan Lai, Yanying Yu, Wei Xian, et al.
iScience (2022) Vol. 25, Iss. 4, pp. 104136-104136
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Mucosal immunology of the ocular surface
Cintia S. de Paiva, Anthony J. St. Leger, Rachel R. Caspi
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1143-1157
Open Access | Times Cited: 57
Time to Kill and Time to Heal: The Multifaceted Role of Lactoferrin and Lactoferricin in Host Defense
Anna Ohradanova‐Repic, Romana Praženicová, Laura Gebetsberger, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1056-1056
Open Access | Times Cited: 27
Lysozyme: A Natural Product with Multiple and Useful Antiviral Properties
Alberta Bergamo, Gianni Sava
Molecules (2024) Vol. 29, Iss. 3, pp. 652-652
Open Access | Times Cited: 9
Lactoferrin as a Human Genome “Guardian”—An Overall Point of View
Iwona Bukowska‐Ośko, Dorota Sulejczak, Katarzyna Kaczyńska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5248-5248
Open Access | Times Cited: 32
The potential of lactoferrin as antiviral and immune-modulating agent in viral infectious diseases
Furkan Eker, Hatice Duman, Melih Ertürk, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
The Gut Virome and Human Health: From Diversity to Personalized Medicine
Rahul Harikumar Lathakumari, K.V. Leela, Anusha Gopinathan, et al.
Engineering Microbiology (2025), pp. 100191-100191
Open Access
Impact of Maternal Exposure to SARS-CoV-2 on Immunological Components of Breast Milk
Nayara Gomes Graciliano, Marília Oliveira Fonseca Goulart, Alane Cabral Menezes de Oliveira
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2600-2600
Open Access
Bovine lactoferrin inhibits SARS‐CoV‐2 and SARS‐CoV‐1 by targeting the RdRp complex and alleviates viral infection in the hamster model
Shiting He, Hongbo Qin, Lin Guan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 21
Evaluation of SARS-CoV-2 isolation in cell culture from nasal/nasopharyngeal swabs or saliva specimens of patients with COVID-19
Shunsuke Yazawa, Emiko Yamazaki, Yumiko Saga, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Milk antibody response after 3rd COVID-19 vaccine and SARS-CoV-2 infection and implications for infant protection
Yarden Golan, Mikias Ilala, Lin Li, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107767-107767
Open Access | Times Cited: 8
Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin
Anna Ohradanova‐Repic, Rostislav Škrabana, Laura Gebetsberger, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Viruses and Human Milk: Transmission or Protection?
Rachele Francese, Chiara Peila, Manuela Donalisio, et al.
Advances in Nutrition (2023) Vol. 14, Iss. 6, pp. 1389-1415
Open Access | Times Cited: 7
Lactoferrin Binds through Its N-Terminus to the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
Patrik Babulic, Ondrej Cehlár, Gabriela Ondrovičová, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1021-1021
Open Access | Times Cited: 2
Molecular mimicry of the receptor-binding domain of the SARS-CoV-2 spike protein: from the interaction of spike-specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin
Sokolov Av, Irina Isakova–Sivak, Daria Mezhenskaya, et al.
BioMetals (2022) Vol. 36, Iss. 3, pp. 437-462
Open Access | Times Cited: 10
Vertical Transmission and Maternal Passive Immunity post-SARS-CoV-2
Hanie Karimi, Vahid Mansouri, Nima Rezaei
Future Virology (2023) Vol. 18, Iss. 13, pp. 895-912
Open Access | Times Cited: 5
Antiviral properties of milk proteins and peptides against SARS-COV-2: A review
Parminder Singh, Janak Dhakal, Pavan Kumar
Journal of Functional Foods (2024) Vol. 117, pp. 106237-106237
Open Access | Times Cited: 1
Lactoferrin Supplementation in Preventing and Protecting from SARS-CoV-2 Infection: Is There Any Role in General and Special Populations? An Updated Review of Literature
Paolo Manzoni, Alessandro Messina, Chiara Germano, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10248-10248
Open Access | Times Cited: 1
Immunomodulatory effect of bovine lactoferrin during SARS-CoV-2 infection
Andréa Marques Vieira da Silva, Thiago Lazari Machado, Raphaela Delmondes do Nascimento, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
A comprehensive review of research advances in the study of lactoferrin to treat viral infections
Amna Shafqat, Maochen Li, Zakirullah Zakirullah, et al.
Life Sciences (2024), pp. 123340-123340
Closed Access | Times Cited: 1
Inhibition of In Vitro Infection of Hepatitis B Virus by Human Breastmilk
Yuqian Luo, Kuanhui Xiang, Jingli Liu, et al.
Nutrients (2022) Vol. 14, Iss. 8, pp. 1561-1561
Open Access | Times Cited: 7
SARS-CoV-2 specific antibody trajectories in mothers and infants over two months following maternal infection
Mélanie Martin, Monica Keith, Ryan M. Pace, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Breastmilk—Old but Not Obsolete: from the Safety of Breastfeeding During the Coronavirus Disease 2019 Pandemic to Broad Antiviral Drug Development
Kuanhui Xiang, Yi-Hua Zhou
Maternal-Fetal Medicine (2023) Vol. 5, Iss. 2, pp. 69-70
Open Access | Times Cited: 2
Recent advances in the exploration and discovery of SARS-CoV-2 inhibitory peptides from edible animal proteins
Xiaoyue Kong, Wei Wang, Yizhi Zhong, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access
Eight-Fold Increased COVID-19 Mortality in Autosomal Dominant Tubulointerstitial Kidney Disease due to MUC1 Mutations: An Observational Study
Kendrah Kidd, Adrienne H. Williams, Abbigail Taylor, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Eight-Fold Increased COVID-19 Mortality in Autosomal Dominant Tubulointerstitial Kidney Disease due to MUC1 Mutations: An Observational Study
Kendrah Kidd, Adrienne H. Williams, Abbigail Taylor, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top